This site uses cookies for analytics and advertising. None of them are stored until you agree. Details
Thermo Fisher Scientific Inc
AI synthesizes chart patterns, technical composite scores, earnings surprises, and valuation multiples to build target price scenarios.
This forecast is a statistical estimate based on historical data and does not guarantee future results. Not investment advice.
| Indicator | Value | Signal |
|---|---|---|
| SMA (5) | 608.68 | Sell |
| SMA (20) | 612.11 | Sell |
| SMA (50) | 576.54 | Buy |
| SMA (200) | 536.51 | Buy |
| EMA (12) | 609.95 | Sell |
| EMA (26) | 601.43 | Buy |
| EMA (50) | 579.03 | Buy |
| WMA (20) | 613.55 | Sell |
| DEMA (20) | 620.08 | Sell |
| TEMA (20) | 611.31 | Sell |
| MACD (12, 26, 9) | macd: 8.52 / signal: 13.45 / histogram: -4.92 | Sell |
| ADX / DMI (14) | adx: 29.98 / pdi: 21.86 / mdi: 17.54 | Buy |
| Ichimoku Cloud (9, 26, 52) | tenkan: 612.41 / kijun: 605.7 / spanA: 557.02 / spanB: 513.61 | Buy |
| Parabolic SAR (0.02, 0.2) | 628.98 | Sell |
| Aroon (25) | up: 56 / down: 0 | Buy |
| Supertrend (10, 3) | supertrend: 582.81 / direction: 1 | Buy |
| Linear Regression Slope (20) | 0.07 | Buy |
| 52-Week High Breakout | high52w: 647 / low52w: 435.27 / pctFromHigh: -6.88 | Neutral |
| Cup with Handle (52w) | pivotPrice: 588.56 / handleLow: 564.4 / depthPct: 32.41 | Buy |
Essential valuation, profitability, and balance sheet metrics viewed on TradingView and financial terminals
Historical quarterly earnings (EPS & surprise) and forward consensus estimates
| Period | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|
| 2025-09 | $5.79 | $5.50 | +5.32% |
| 2025-12 | $6.57 | $6.45 | +1.87% |
| 2026-03 | $5.44 | $5.24 | +3.79% |
| 2026-06 | $6.03 | $5.71 | +5.60% |
| Period | Avg EPS Estimate | EPS Growth Est. | Avg Revenue Estimate | Revenue Growth Est. |
|---|---|---|---|---|
| Current Quarter (0Q) | $6.40 | +10.6% | USD 12B | +7.5% |
| Next Quarter (+1Q) | $7.28 | +10.8% | USD 12.9B | +5.8% |
| Current Year (0Y) | $25.13 | +9.9% | USD 47.9B | +7.4% |
| Next Year (+1Y) | $27.53 | +9.6% | USD 50.3B | +5.1% |
Nearest Expiration: Sep 11, 2026
Based on the nearest-expiry options chain.
Symbol-level short-interest metrics and official market-wide margin statistics
The sources below cover the whole market, not this symbol specifically.
FINRA Margin StatisticsAggregate U.S. margin debt, free credit balances in margin accounts, and free credit balances in cash accounts, published monthly by FINRA across all member firms.Cadence: MonthlyJPX Margin Trading Balances (信用取引残高)Weekly margin trading (buy/sell) balances for listed Japanese equities, published by Japan Exchange Group.Cadence: WeeklyJPX Short Selling Statistics (空売り集計)Daily aggregate short-selling value/ratio statistics for the Japanese equity market, published by Japan Exchange Group.Cadence: DailyAnalyst recommendation distribution and price targets
| Date | Firm | Action | Grade |
|---|---|---|---|
| Sep 3, 2026 | CLSA | init | Outperform |
| Jul 27, 2026 | Piper Sandler | main | Neutral → Neutral |
| Jul 27, 2026 | Morgan Stanley | main | Overweight → Overweight |
| Jul 24, 2026 | RBC Capital | main | Sector Perform → Sector Perform |
| Jul 24, 2026 | Barclays | main | Overweight → Overweight |
| Jul 6, 2026 | Evercore ISI Group | main | Outperform → Outperform |
| Jun 11, 2026 | Piper Sandler | init | Neutral |
| Jun 3, 2026 | HSBC | down | Buy → Hold |
| May 8, 2026 | Wells Fargo | main | Overweight → Overweight |
| Apr 24, 2026 | Stifel | main | Buy → Buy |